ReP USP - Resultado da busca

Artigo de periodico
Translation, cross-cultural adaptation, and validation of the portuguese version of the Rotterdam Elderly Pain Observation Scale (2021)
Seixas-Moizes, Julieta; Boerlage, Anneke; Lia, Érica Negrini; Santos, Lucas Emmanuel Lopes e; Zucoloto, Miriane Lucindo; Dach, Fabíola; Papassidero, Priscila Colavite; Wichert-Ana, Laís Almeida Leal; Della Pasqua, Oscar; Wiesebron, Marianne Louise; Icuma, Tatiana Reis; Lanchote, Vera Lucia; Coelho, Eduardo Barbosa; Tibboel, Dick; Wichert-Ana, Lauro
Source: Dementia and Geriatric Cognitive Disorders Extra. Unidades: FMRP, FCFRP
Subjects: DOR, IDOSOS, ESTUDOS DE VALIDAÇÃO, DEMÊNCIA, ESTUDOS MULTICÊNTRICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SEIXAS-MOIZES, Julieta et al. Translation, cross-cultural adaptation, and validation of the portuguese version of the Rotterdam Elderly Pain Observation Scale. Dementia and Geriatric Cognitive Disorders Extra, v. 11, n. 3, p. 314-323, 2021Tradução . . Disponível em: https://doi.org/10.1159/000520455. Acesso em: 01 nov. 2024.
APA
Seixas-Moizes, J., Boerlage, A., Lia, É. N., Santos, L. E. L. e, Zucoloto, M. L., Dach, F., et al. (2021). Translation, cross-cultural adaptation, and validation of the portuguese version of the Rotterdam Elderly Pain Observation Scale. Dementia and Geriatric Cognitive Disorders Extra, 11( 3), 314-323. doi:10.1159/000520455
NLM
Seixas-Moizes J, Boerlage A, Lia ÉN, Santos LEL e, Zucoloto ML, Dach F, Papassidero PC, Wichert-Ana LAL, Della Pasqua O, Wiesebron ML, Icuma TR, Lanchote VL, Coelho EB, Tibboel D, Wichert-Ana L. Translation, cross-cultural adaptation, and validation of the portuguese version of the Rotterdam Elderly Pain Observation Scale [Internet]. Dementia and Geriatric Cognitive Disorders Extra. 2021 ; 11( 3): 314-323.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1159/000520455
Vancouver
Seixas-Moizes J, Boerlage A, Lia ÉN, Santos LEL e, Zucoloto ML, Dach F, Papassidero PC, Wichert-Ana LAL, Della Pasqua O, Wiesebron ML, Icuma TR, Lanchote VL, Coelho EB, Tibboel D, Wichert-Ana L. Translation, cross-cultural adaptation, and validation of the portuguese version of the Rotterdam Elderly Pain Observation Scale [Internet]. Dementia and Geriatric Cognitive Disorders Extra. 2021 ; 11( 3): 314-323.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1159/000520455
Artigo de periodico
Sensitive LC-MS/MS methods for amphotericin B analysis in cerebrospinal fluid, plasma, plasma ultrafiltrate, and urine: application to clinical pharmacokinetics (2021)
Pippa, Leandro Francisco ; Pereira, Maria Paula Marques ; Silva, Anna Christina Tojal da; Vilar, Fernando Crivelenti; Haes, Tissiana Marques de; Fonseca, Benedito Antonio Lopes da; Martinez, Roberto ; Coelho, Eduardo Barbosa ; Wichert-Ana, Lauro; Lanchote, Vera Lucia
Source: Frontiers in Chemistry. Unidades: FCFRP, FMRP, EERP
Subjects: ANTIFÚNGICOS, LÍQUIDO CEFALORRAQUIDIANO, FARMACOCINÉTICA, PLASMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PIPPA, Leandro Francisco et al. Sensitive LC-MS/MS methods for amphotericin B analysis in cerebrospinal fluid, plasma, plasma ultrafiltrate, and urine: application to clinical pharmacokinetics. Frontiers in Chemistry, v. 9, p. 1-14, 2021Tradução . . Disponível em: https://doi.org/10.3389/fchem.2021.782131. Acesso em: 01 nov. 2024.
APA
Pippa, L. F., Pereira, M. P. M., Silva, A. C. T. da, Vilar, F. C., Haes, T. M. de, Fonseca, B. A. L. da, et al. (2021). Sensitive LC-MS/MS methods for amphotericin B analysis in cerebrospinal fluid, plasma, plasma ultrafiltrate, and urine: application to clinical pharmacokinetics. Frontiers in Chemistry, 9, 1-14. doi:10.3389/fchem.2021.782131
NLM
Pippa LF, Pereira MPM, Silva ACT da, Vilar FC, Haes TM de, Fonseca BAL da, Martinez R, Coelho EB, Wichert-Ana L, Lanchote VL. Sensitive LC-MS/MS methods for amphotericin B analysis in cerebrospinal fluid, plasma, plasma ultrafiltrate, and urine: application to clinical pharmacokinetics [Internet]. Frontiers in Chemistry. 2021 ; 9 1-14.[citado 2024 nov. 01 ] Available from: https://doi.org/10.3389/fchem.2021.782131
Vancouver
Pippa LF, Pereira MPM, Silva ACT da, Vilar FC, Haes TM de, Fonseca BAL da, Martinez R, Coelho EB, Wichert-Ana L, Lanchote VL. Sensitive LC-MS/MS methods for amphotericin B analysis in cerebrospinal fluid, plasma, plasma ultrafiltrate, and urine: application to clinical pharmacokinetics [Internet]. Frontiers in Chemistry. 2021 ; 9 1-14.[citado 2024 nov. 01 ] Available from: https://doi.org/10.3389/fchem.2021.782131
Artigo de periodico
Nifedipine does not alter the pharmacokinetics of venlafaxine enantiomers in healthy subjects phenotyped for CYP2D6, CYP2C19, and CYP3A (2021)
Tozatto, Eduardo; Benzi, Jhohann Richard de Lima ; Rocha, Adriana; Coelho, Eduardo Barbosa ; Lanchote, Vera Lucia
Source: The Journal of Clinical Pharmacology. Unidades: FCFRP, FMRP
Subjects: FÁRMACOS, HIPERTENSÃO, FARMACOCINÉTICA, ANTIDEPRESSIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TOZATTO, Eduardo et al. Nifedipine does not alter the pharmacokinetics of venlafaxine enantiomers in healthy subjects phenotyped for CYP2D6, CYP2C19, and CYP3A. The Journal of Clinical Pharmacology, v. 61, n. 3, p. 319-327, 2021Tradução . . Disponível em: https://doi.org/10.1002/jcph.1745. Acesso em: 01 nov. 2024.
APA
Tozatto, E., Benzi, J. R. de L., Rocha, A., Coelho, E. B., & Lanchote, V. L. (2021). Nifedipine does not alter the pharmacokinetics of venlafaxine enantiomers in healthy subjects phenotyped for CYP2D6, CYP2C19, and CYP3A. The Journal of Clinical Pharmacology, 61( 3), 319-327. doi:10.1002/jcph.1745
NLM
Tozatto E, Benzi JR de L, Rocha A, Coelho EB, Lanchote VL. Nifedipine does not alter the pharmacokinetics of venlafaxine enantiomers in healthy subjects phenotyped for CYP2D6, CYP2C19, and CYP3A [Internet]. The Journal of Clinical Pharmacology. 2021 ; 61( 3): 319-327.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1002/jcph.1745
Vancouver
Tozatto E, Benzi JR de L, Rocha A, Coelho EB, Lanchote VL. Nifedipine does not alter the pharmacokinetics of venlafaxine enantiomers in healthy subjects phenotyped for CYP2D6, CYP2C19, and CYP3A [Internet]. The Journal of Clinical Pharmacology. 2021 ; 61( 3): 319-327.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1002/jcph.1745
Artigo de periodico
Limited sampling modeling for estimation of phenotypic metrics for CYP enzymes and the ABCB1 transporter using a cocktail approach (2020)
Coelho, Eduardo Barbosa ; Cusinato, Diego Alberto Ciscato ; Ximenez, João Paulo Bianchi ; Lanchote, Vera Lucia ; Struchiner, Claudio José; Suarez-Kurtz, Guilherme
Source: Frontiers in Pharmacology. Unidades: FMRP, FCFRP
Subjects: CAFEÍNA, ANTI-HISTAMÍNICOS, FÁRMACOS (SISTEMA DIGESTÓRIO), FENÓTIPOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COELHO, Eduardo Barbosa et al. Limited sampling modeling for estimation of phenotypic metrics for CYP enzymes and the ABCB1 transporter using a cocktail approach. Frontiers in Pharmacology, v. 11, p. 1-7, 2020Tradução . . Disponível em: https://doi.org/10.3389/fphar.2020.00022. Acesso em: 01 nov. 2024.
APA
Coelho, E. B., Cusinato, D. A. C., Ximenez, J. P. B., Lanchote, V. L., Struchiner, C. J., & Suarez-Kurtz, G. (2020). Limited sampling modeling for estimation of phenotypic metrics for CYP enzymes and the ABCB1 transporter using a cocktail approach. Frontiers in Pharmacology, 11, 1-7. doi:10.3389/fphar.2020.00022
NLM
Coelho EB, Cusinato DAC, Ximenez JPB, Lanchote VL, Struchiner CJ, Suarez-Kurtz G. Limited sampling modeling for estimation of phenotypic metrics for CYP enzymes and the ABCB1 transporter using a cocktail approach [Internet]. Frontiers in Pharmacology. 2020 ; 11 1-7.[citado 2024 nov. 01 ] Available from: https://doi.org/10.3389/fphar.2020.00022
Vancouver
Coelho EB, Cusinato DAC, Ximenez JPB, Lanchote VL, Struchiner CJ, Suarez-Kurtz G. Limited sampling modeling for estimation of phenotypic metrics for CYP enzymes and the ABCB1 transporter using a cocktail approach [Internet]. Frontiers in Pharmacology. 2020 ; 11 1-7.[citado 2024 nov. 01 ] Available from: https://doi.org/10.3389/fphar.2020.00022
Artigo de periodico
Direct chiral LC-MS/MS analysis of fexofenadine enantiomers in plasma and urine with application in a maternal-fetal pharmacokinetic study (2020)
Pinto, Leonardo Santos Ribeiro; Vale, Gabriel Tavares do ; Moreira, Fernanda de Lima ; Pereira, Maria Paula Marques ; Coelho, Eduardo Barbosa ; Cavalli, Ricardo de Carvalho ; Lanchote, Vera Lucia
Source: Journal of Chromatography B. Unidades: FCFRP, FMRP, EERP
Subjects: ANTI-HISTAMÍNICOS, FARMACOCINÉTICA, CROMATOGRAFIA LÍQUIDA DE ALTA PRESSÃO, PLASMA, GRAVIDEZ, ESPECTROMETRIA DE MASSAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PINTO, Leonardo Santos Ribeiro et al. Direct chiral LC-MS/MS analysis of fexofenadine enantiomers in plasma and urine with application in a maternal-fetal pharmacokinetic study. Journal of Chromatography B, v. 1145, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.jchromb.2020.122094. Acesso em: 01 nov. 2024.
APA
Pinto, L. S. R., Vale, G. T. do, Moreira, F. de L., Pereira, M. P. M., Coelho, E. B., Cavalli, R. de C., & Lanchote, V. L. (2020). Direct chiral LC-MS/MS analysis of fexofenadine enantiomers in plasma and urine with application in a maternal-fetal pharmacokinetic study. Journal of Chromatography B, 1145. doi:10.1016/j.jchromb.2020.122094
NLM
Pinto LSR, Vale GT do, Moreira F de L, Pereira MPM, Coelho EB, Cavalli R de C, Lanchote VL. Direct chiral LC-MS/MS analysis of fexofenadine enantiomers in plasma and urine with application in a maternal-fetal pharmacokinetic study [Internet]. Journal of Chromatography B. 2020 ; 1145[citado 2024 nov. 01 ] Available from: https://doi.org/10.1016/j.jchromb.2020.122094
Vancouver
Pinto LSR, Vale GT do, Moreira F de L, Pereira MPM, Coelho EB, Cavalli R de C, Lanchote VL. Direct chiral LC-MS/MS analysis of fexofenadine enantiomers in plasma and urine with application in a maternal-fetal pharmacokinetic study [Internet]. Journal of Chromatography B. 2020 ; 1145[citado 2024 nov. 01 ] Available from: https://doi.org/10.1016/j.jchromb.2020.122094
Artigo de periodico
Effect of lercanidipine on the pharmacokinetics-pharmacodynamics of carvedilol enantiomers in patients with chronic kidney disease (2020)
Schaab, Estela Hanauer; Lanchote, Vera Lucia ; Nardotto, Glauco Henrique Balthazar ; Pereira, Maria Paula Marques ; Dantas, Márcio ; Paiva, Carlos Eduardo; Coelho, Eduardo Barbosa
Source: The Journal of Clinical Pharmacology. Unidades: FCFRP, FMRP
Subjects: NEFROPATIAS, INTERAÇÃO ENTRE ALIMENTOS E MEDICAMENTOS, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SCHAAB, Estela Hanauer et al. Effect of lercanidipine on the pharmacokinetics-pharmacodynamics of carvedilol enantiomers in patients with chronic kidney disease. The Journal of Clinical Pharmacology, v. 60, n. 1, p. 75-85, 2020Tradução . . Disponível em: https://doi.org/10.1002/jcph.1485. Acesso em: 01 nov. 2024.
APA
Schaab, E. H., Lanchote, V. L., Nardotto, G. H. B., Pereira, M. P. M., Dantas, M., Paiva, C. E., & Coelho, E. B. (2020). Effect of lercanidipine on the pharmacokinetics-pharmacodynamics of carvedilol enantiomers in patients with chronic kidney disease. The Journal of Clinical Pharmacology, 60( 1), 75-85. doi:10.1002/jcph.1485
NLM
Schaab EH, Lanchote VL, Nardotto GHB, Pereira MPM, Dantas M, Paiva CE, Coelho EB. Effect of lercanidipine on the pharmacokinetics-pharmacodynamics of carvedilol enantiomers in patients with chronic kidney disease [Internet]. The Journal of Clinical Pharmacology. 2020 ; 60( 1): 75-85.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1002/jcph.1485
Vancouver
Schaab EH, Lanchote VL, Nardotto GHB, Pereira MPM, Dantas M, Paiva CE, Coelho EB. Effect of lercanidipine on the pharmacokinetics-pharmacodynamics of carvedilol enantiomers in patients with chronic kidney disease [Internet]. The Journal of Clinical Pharmacology. 2020 ; 60( 1): 75-85.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1002/jcph.1485
Artigo de periodico
LC-MS/MS analysis of the plasma concentrations of a cocktail of 5 cytochrome P450 and P-glycoprotein probe substrates and their metabolites using subtherapeutic doses (2019)
Cusinato, Diego Alberto Ciscato ; Filgueira, Gabriela Campos de Oliveira ; Rocha, Adriana; Cintra, Monica Akissue de Camargo Teixeira; Lanchote, Vera Lucia ; Coelho, Eduardo Barbosa
Source: Journal of Pharmaceutical and Biomedical Analysis. Unidades: FCFRP, FMRP
Subjects: CROMATOGRAFIA LÍQUIDA, ESPECTROMETRIA DE MASSAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CUSINATO, Diego Alberto Ciscato et al. LC-MS/MS analysis of the plasma concentrations of a cocktail of 5 cytochrome P450 and P-glycoprotein probe substrates and their metabolites using subtherapeutic doses. Journal of Pharmaceutical and Biomedical Analysis, v. 164, p. 430-441, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.jpba.2018.10.029. Acesso em: 01 nov. 2024.
APA
Cusinato, D. A. C., Filgueira, G. C. de O., Rocha, A., Cintra, M. A. de C. T., Lanchote, V. L., & Coelho, E. B. (2019). LC-MS/MS analysis of the plasma concentrations of a cocktail of 5 cytochrome P450 and P-glycoprotein probe substrates and their metabolites using subtherapeutic doses. Journal of Pharmaceutical and Biomedical Analysis, 164, 430-441. doi:10.1016/j.jpba.2018.10.029
NLM
Cusinato DAC, Filgueira GC de O, Rocha A, Cintra MA de CT, Lanchote VL, Coelho EB. LC-MS/MS analysis of the plasma concentrations of a cocktail of 5 cytochrome P450 and P-glycoprotein probe substrates and their metabolites using subtherapeutic doses [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2019 ; 164 430-441.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1016/j.jpba.2018.10.029
Vancouver
Cusinato DAC, Filgueira GC de O, Rocha A, Cintra MA de CT, Lanchote VL, Coelho EB. LC-MS/MS analysis of the plasma concentrations of a cocktail of 5 cytochrome P450 and P-glycoprotein probe substrates and their metabolites using subtherapeutic doses [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2019 ; 164 430-441.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1016/j.jpba.2018.10.029
Trabalho de evento-anais periodico
Hormonal status affects plasma exposure of tamoxifen and its main metabolites in tamoxifen-treated breast cancer patients (2019)
Ximenez, João Paulo Bianchi ; Andrade, Jurandyr Moreira de ; Marques, Maria Paula ; Coelho, Eduardo Barbosa ; Suarez-Kurtz, Guilherme ; Lanchote, Vera Lucia
Source: BMC Pharmacology and Toxicology. Conference titles: Latin American Congress of Clinical and Laboratorial Toxicology - ToxiLatin. Unidades: FMRP, FCFRP
Subjects: NEOPLASIAS MAMÁRIAS, RECEPTORES DE DROGA, QUIMIOTERAPIA, ESTRÓGENOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
XIMENEZ, João Paulo Bianchi et al. Hormonal status affects plasma exposure of tamoxifen and its main metabolites in tamoxifen-treated breast cancer patients. BMC Pharmacology and Toxicology. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1186/s40360-019-0358-y. Acesso em: 01 nov. 2024. , 2019
APA
Ximenez, J. P. B., Andrade, J. M. de, Marques, M. P., Coelho, E. B., Suarez-Kurtz, G., & Lanchote, V. L. (2019). Hormonal status affects plasma exposure of tamoxifen and its main metabolites in tamoxifen-treated breast cancer patients. BMC Pharmacology and Toxicology. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1186/s40360-019-0358-y
NLM
Ximenez JPB, Andrade JM de, Marques MP, Coelho EB, Suarez-Kurtz G, Lanchote VL. Hormonal status affects plasma exposure of tamoxifen and its main metabolites in tamoxifen-treated breast cancer patients [Internet]. BMC Pharmacology and Toxicology. 2019 ; 20 [10] .[citado 2024 nov. 01 ] Available from: https://doi.org/10.1186/s40360-019-0358-y
Vancouver
Ximenez JPB, Andrade JM de, Marques MP, Coelho EB, Suarez-Kurtz G, Lanchote VL. Hormonal status affects plasma exposure of tamoxifen and its main metabolites in tamoxifen-treated breast cancer patients [Internet]. BMC Pharmacology and Toxicology. 2019 ; 20 [10] .[citado 2024 nov. 01 ] Available from: https://doi.org/10.1186/s40360-019-0358-y
Artigo de periodico
Evaluation of potential herbal-drug interactions of a standardized propolis extract (EPP-AF®) using an in vivo cocktail approach (2019)
Cusinato, Diego Alberto Ciscato ; Martinez, Edson Zangiacomi ; Cintra, Mônica T. C.; Filgueira, Gabriela Campos de Oliveira ; Berretta, Andresa A.; Lanchote, Vera Lucia ; Coelho, Eduardo Barbosa
Source: Journal of Ethnopharmacology. Unidades: FMRP, FCFRP
Subjects: PRÓPOLIS, FÁRMACOS DE ORIGEM ANIMAL, METABOLISMO, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CUSINATO, Diego Alberto Ciscato et al. Evaluation of potential herbal-drug interactions of a standardized propolis extract (EPP-AF®) using an in vivo cocktail approach. Journal of Ethnopharmacology, v. 245, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.jep.2019.112174. Acesso em: 01 nov. 2024.
APA
Cusinato, D. A. C., Martinez, E. Z., Cintra, M. T. C., Filgueira, G. C. de O., Berretta, A. A., Lanchote, V. L., & Coelho, E. B. (2019). Evaluation of potential herbal-drug interactions of a standardized propolis extract (EPP-AF®) using an in vivo cocktail approach. Journal of Ethnopharmacology, 245. doi:10.1016/j.jep.2019.112174
NLM
Cusinato DAC, Martinez EZ, Cintra MTC, Filgueira GC de O, Berretta AA, Lanchote VL, Coelho EB. Evaluation of potential herbal-drug interactions of a standardized propolis extract (EPP-AF®) using an in vivo cocktail approach [Internet]. Journal of Ethnopharmacology. 2019 ; 245[citado 2024 nov. 01 ] Available from: https://doi.org/10.1016/j.jep.2019.112174
Vancouver
Cusinato DAC, Martinez EZ, Cintra MTC, Filgueira GC de O, Berretta AA, Lanchote VL, Coelho EB. Evaluation of potential herbal-drug interactions of a standardized propolis extract (EPP-AF®) using an in vivo cocktail approach [Internet]. Journal of Ethnopharmacology. 2019 ; 245[citado 2024 nov. 01 ] Available from: https://doi.org/10.1016/j.jep.2019.112174
Artigo de periodico
Analysis of unbound plasma concentration of oxcarbazepine and the 10-hydroxycarbazepine enantiomers by liquid chromatography with tandem mass spectrometry in healthy volunteers (2018)
Antunes, Natalícia de Jesus; Wichert-Ana, Lauro ; Coelho, Eduardo Barbosa ; Della Pasqua, Oscar; Alexandre Júnior, Veriano; Takayanagui, Osvaldo Massaiti ; Marques, Maria Paula ; Lanchote, Vera Lucia
Source: Journal of Pharmaceutical and Biomedical Analysis. Unidades: FMRP, FCFRP
Subjects: ANTICONVULSIVANTES, FARMACOCINÉTICA, ESPECTROMETRIA DE MASSAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ANTUNES, Natalícia de Jesus et al. Analysis of unbound plasma concentration of oxcarbazepine and the 10-hydroxycarbazepine enantiomers by liquid chromatography with tandem mass spectrometry in healthy volunteers. Journal of Pharmaceutical and Biomedical Analysis, v. 149, p. 442-447, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.jpba.2017.11.041. Acesso em: 01 nov. 2024.
APA
Antunes, N. de J., Wichert-Ana, L., Coelho, E. B., Della Pasqua, O., Alexandre Júnior, V., Takayanagui, O. M., et al. (2018). Analysis of unbound plasma concentration of oxcarbazepine and the 10-hydroxycarbazepine enantiomers by liquid chromatography with tandem mass spectrometry in healthy volunteers. Journal of Pharmaceutical and Biomedical Analysis, 149, 442-447. doi:10.1016/j.jpba.2017.11.041
NLM
Antunes N de J, Wichert-Ana L, Coelho EB, Della Pasqua O, Alexandre Júnior V, Takayanagui OM, Marques MP, Lanchote VL. Analysis of unbound plasma concentration of oxcarbazepine and the 10-hydroxycarbazepine enantiomers by liquid chromatography with tandem mass spectrometry in healthy volunteers [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2018 ; 149 442-447.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1016/j.jpba.2017.11.041
Vancouver
Antunes N de J, Wichert-Ana L, Coelho EB, Della Pasqua O, Alexandre Júnior V, Takayanagui OM, Marques MP, Lanchote VL. Analysis of unbound plasma concentration of oxcarbazepine and the 10-hydroxycarbazepine enantiomers by liquid chromatography with tandem mass spectrometry in healthy volunteers [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2018 ; 149 442-447.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1016/j.jpba.2017.11.041
Artigo de periodico
Enantioselectivity in the metabolism of cyclophosphamide in patients with multiple or systemic sclerosis (2017)
Castro, Francine Attié de; Simões, Belinda Pinto; Coelho, Eduardo Barbosa; Lanchote, Vera Lúcia
Source: The Journal of Clinical Pharmacology. Unidades: FMRP, FCFRP
Subjects: CITOCINAS, FÁRMACOS IMUNOSSUPRESSORES, ESCLEROSE MÚLTIPLA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CASTRO, Francine Attié de et al. Enantioselectivity in the metabolism of cyclophosphamide in patients with multiple or systemic sclerosis. The Journal of Clinical Pharmacology, v. 57, n. 6, p. 784-795, 2017Tradução . . Disponível em: https://doi.org/10.1002/jcph.863. Acesso em: 01 nov. 2024.
APA
Castro, F. A. de, Simões, B. P., Coelho, E. B., & Lanchote, V. L. (2017). Enantioselectivity in the metabolism of cyclophosphamide in patients with multiple or systemic sclerosis. The Journal of Clinical Pharmacology, 57( 6), 784-795. doi:10.1002/jcph.863
NLM
Castro FA de, Simões BP, Coelho EB, Lanchote VL. Enantioselectivity in the metabolism of cyclophosphamide in patients with multiple or systemic sclerosis [Internet]. The Journal of Clinical Pharmacology. 2017 ; 57( 6): 784-795.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1002/jcph.863
Vancouver
Castro FA de, Simões BP, Coelho EB, Lanchote VL. Enantioselectivity in the metabolism of cyclophosphamide in patients with multiple or systemic sclerosis [Internet]. The Journal of Clinical Pharmacology. 2017 ; 57( 6): 784-795.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1002/jcph.863
Artigo de periodico
The SLCO1A2 -189_-188InsA polymorphism reduces clearance of rocuronium in patients submitted to elective surgeries (2017)
Costa, A. C. C.; Coelho, Eduardo Barbosa; Lanchote, Vera Lúcia; Correia, B. V.; Abumansur, Juliana Trench; Lauretti, Gabriela Rocha; Moraes, N. V. de
Source: European Journal of Clinical Pharmacology. Unidades: FMRP, FCFRP
Subjects: FARMACOGENÉTICA, FARMACOCINÉTICA, POLIMORFISMO, BLOQUEIO NERVOSO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COSTA, A. C. C. et al. The SLCO1A2 -189_-188InsA polymorphism reduces clearance of rocuronium in patients submitted to elective surgeries. European Journal of Clinical Pharmacology, v. 73, n. 8, p. 957-963, 2017Tradução . . Disponível em: https://doi.org/10.1007/s00228-017-2243-1. Acesso em: 01 nov. 2024.
APA
Costa, A. C. C., Coelho, E. B., Lanchote, V. L., Correia, B. V., Abumansur, J. T., Lauretti, G. R., & Moraes, N. V. de. (2017). The SLCO1A2 -189_-188InsA polymorphism reduces clearance of rocuronium in patients submitted to elective surgeries. European Journal of Clinical Pharmacology, 73( 8), 957-963. doi:10.1007/s00228-017-2243-1
NLM
Costa ACC, Coelho EB, Lanchote VL, Correia BV, Abumansur JT, Lauretti GR, Moraes NV de. The SLCO1A2 -189_-188InsA polymorphism reduces clearance of rocuronium in patients submitted to elective surgeries [Internet]. European Journal of Clinical Pharmacology. 2017 ; 73( 8): 957-963.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1007/s00228-017-2243-1
Vancouver
Costa ACC, Coelho EB, Lanchote VL, Correia BV, Abumansur JT, Lauretti GR, Moraes NV de. The SLCO1A2 -189_-188InsA polymorphism reduces clearance of rocuronium in patients submitted to elective surgeries [Internet]. European Journal of Clinical Pharmacology. 2017 ; 73( 8): 957-963.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1007/s00228-017-2243-1
Artigo de periodico
Population pharmacokinetics of carvedilol enantiomers and their metabolites in healthy subjects and type-2 diabetes patients (2017)
Nardotto, Glauco H. B; Lanchote, Vera Lúcia; Coelho, Eduardo Barbosa; Della Pasqua, Oscar
Source: European Journal of Pharmaceutical Sciences. Unidades: FCFRP, FMRP
Subjects: FARMACOLOGIA, DIABETES MELLITUS, ANTAGONISMO DE DROGAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NARDOTTO, Glauco H. B et al. Population pharmacokinetics of carvedilol enantiomers and their metabolites in healthy subjects and type-2 diabetes patients. European Journal of Pharmaceutical Sciences, v. 109S, p. S108-S115, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.ejps.2017.05.033. Acesso em: 01 nov. 2024.
APA
Nardotto, G. H. B., Lanchote, V. L., Coelho, E. B., & Della Pasqua, O. (2017). Population pharmacokinetics of carvedilol enantiomers and their metabolites in healthy subjects and type-2 diabetes patients. European Journal of Pharmaceutical Sciences, 109S, S108-S115. doi:10.1016/j.ejps.2017.05.033
NLM
Nardotto GHB, Lanchote VL, Coelho EB, Della Pasqua O. Population pharmacokinetics of carvedilol enantiomers and their metabolites in healthy subjects and type-2 diabetes patients [Internet]. European Journal of Pharmaceutical Sciences. 2017 ; 109S S108-S115.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1016/j.ejps.2017.05.033
Vancouver
Nardotto GHB, Lanchote VL, Coelho EB, Della Pasqua O. Population pharmacokinetics of carvedilol enantiomers and their metabolites in healthy subjects and type-2 diabetes patients [Internet]. European Journal of Pharmaceutical Sciences. 2017 ; 109S S108-S115.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1016/j.ejps.2017.05.033
Tese (Doutorado)
Influência do EPP-AF® na atividade da glicoproteína P e do citocromo P450 em voluntários sadios usando coquetel de marcadores (2017)
Cusinato, Diego Alberto Ciscato; Coelho, Eduardo Barbosa (Orientador)
Unidade: FCFRP
Subjects: FARMÁCIA, PRÓPOLIS, FARMACOCINÉTICA, METABOLISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CUSINATO, Diego Alberto Ciscato. Influência do EPP-AF® na atividade da glicoproteína P e do citocromo P450 em voluntários sadios usando coquetel de marcadores. 2017. Tese (Doutorado) – Universidade de São Paulo, Ribeirão Preto, 2017. Disponível em: http://www.teses.usp.br/teses/disponiveis/60/60134/tde-23112017-101956/. Acesso em: 01 nov. 2024.
APA
Cusinato, D. A. C. (2017). Influência do EPP-AF® na atividade da glicoproteína P e do citocromo P450 em voluntários sadios usando coquetel de marcadores (Tese (Doutorado). Universidade de São Paulo, Ribeirão Preto. Recuperado de http://www.teses.usp.br/teses/disponiveis/60/60134/tde-23112017-101956/
NLM
Cusinato DAC. Influência do EPP-AF® na atividade da glicoproteína P e do citocromo P450 em voluntários sadios usando coquetel de marcadores [Internet]. 2017 ;[citado 2024 nov. 01 ] Available from: http://www.teses.usp.br/teses/disponiveis/60/60134/tde-23112017-101956/
Vancouver
Cusinato DAC. Influência do EPP-AF® na atividade da glicoproteína P e do citocromo P450 em voluntários sadios usando coquetel de marcadores [Internet]. 2017 ;[citado 2024 nov. 01 ] Available from: http://www.teses.usp.br/teses/disponiveis/60/60134/tde-23112017-101956/
Artigo de periodico
Effects of type 2 diabetes mellitus in patients on treatment with glibenclamide and metformin on carvedilol enantiomers metabolism (2017)
Nardotto, Glauco H. B.; Coelho, Eduardo Barbosa; Paiva, Carlos E.; Lanchote, Vera Lúcia
Source: The Journal of Clinical Pharmacology. Unidades: FMRP, FCFRP
Subjects: DIABETES MELLITUS, ANTAGONISTAS, RECEPTORES ADRENÉRGICOS, FREQUÊNCIA CARDÍACA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NARDOTTO, Glauco H. B. et al. Effects of type 2 diabetes mellitus in patients on treatment with glibenclamide and metformin on carvedilol enantiomers metabolism. The Journal of Clinical Pharmacology, v. 57, n. 6, p. 760-769, 2017Tradução . . Disponível em: https://doi.org/10.1002/jcph.864. Acesso em: 01 nov. 2024.
APA
Nardotto, G. H. B., Coelho, E. B., Paiva, C. E., & Lanchote, V. L. (2017). Effects of type 2 diabetes mellitus in patients on treatment with glibenclamide and metformin on carvedilol enantiomers metabolism. The Journal of Clinical Pharmacology, 57( 6), 760-769. doi:10.1002/jcph.864
NLM
Nardotto GHB, Coelho EB, Paiva CE, Lanchote VL. Effects of type 2 diabetes mellitus in patients on treatment with glibenclamide and metformin on carvedilol enantiomers metabolism [Internet]. The Journal of Clinical Pharmacology. 2017 ; 57( 6): 760-769.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1002/jcph.864
Vancouver
Nardotto GHB, Coelho EB, Paiva CE, Lanchote VL. Effects of type 2 diabetes mellitus in patients on treatment with glibenclamide and metformin on carvedilol enantiomers metabolism [Internet]. The Journal of Clinical Pharmacology. 2017 ; 57( 6): 760-769.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1002/jcph.864
Artigo de periodico
Population pharmacokinetics of oxcarbazepine and its metabolite 10-hydroxycarbazepine in healthy subjects (2017)
Antunes, Natalicia de Jesus; van Dijkman, Sven C.; Lanchote, Vera Lúcia; Wichert-Ana, Lauro; Coelho, Eduardo Barbosa; Alexandre Junior, Veriano; Takayanagui, Osvaldo Massaíti; Tozatto, Eduardo; van Hasselt, J.G. Coen; Della Pasqua, Oscar
Source: European Journal of Pharmaceutical Sciences. Unidades: FCFRP, FMRP
Assunto: ANTICONVULSIVANTES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ANTUNES, Natalicia de Jesus et al. Population pharmacokinetics of oxcarbazepine and its metabolite 10-hydroxycarbazepine in healthy subjects. European Journal of Pharmaceutical Sciences, v. 109, p. S116-S123, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.ejps.2017.05.034. Acesso em: 01 nov. 2024.
APA
Antunes, N. de J., van Dijkman, S. C., Lanchote, V. L., Wichert-Ana, L., Coelho, E. B., Alexandre Junior, V., et al. (2017). Population pharmacokinetics of oxcarbazepine and its metabolite 10-hydroxycarbazepine in healthy subjects. European Journal of Pharmaceutical Sciences, 109, S116-S123. doi:10.1016/j.ejps.2017.05.034
NLM
Antunes N de J, van Dijkman SC, Lanchote VL, Wichert-Ana L, Coelho EB, Alexandre Junior V, Takayanagui OM, Tozatto E, van Hasselt JGC, Della Pasqua O. Population pharmacokinetics of oxcarbazepine and its metabolite 10-hydroxycarbazepine in healthy subjects [Internet]. European Journal of Pharmaceutical Sciences. 2017 ; 109 S116-S123.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1016/j.ejps.2017.05.034
Vancouver
Antunes N de J, van Dijkman SC, Lanchote VL, Wichert-Ana L, Coelho EB, Alexandre Junior V, Takayanagui OM, Tozatto E, van Hasselt JGC, Della Pasqua O. Population pharmacokinetics of oxcarbazepine and its metabolite 10-hydroxycarbazepine in healthy subjects [Internet]. European Journal of Pharmaceutical Sciences. 2017 ; 109 S116-S123.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1016/j.ejps.2017.05.034
Artigo de periodico
Influence of verapamil on the pharmacokinetics of oxcarbazepine and of the enantiomers of its 10-hydroxy metabolite in healthy volunteers (2016)
Antunes, Natalícia de Jesus; Wichert-Ana, Lauro; Coelho, Eduardo Barbosa; Pasqua, Oscar Della; Alexandre Junior, Veriano; Takayanagui, Osvaldo Massaiti; Tozatto, Eduardo; Marques, Maria Paula; Lanchote, Vera Lúcia
Source: European Journal of Clinical Pharmacology. Unidades: FCFRP, FMRP
Subjects: ANTICONVULSIVANTES, FARMACOCINÉTICA CLÍNICA, MOLÉCULA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ANTUNES, Natalícia de Jesus et al. Influence of verapamil on the pharmacokinetics of oxcarbazepine and of the enantiomers of its 10-hydroxy metabolite in healthy volunteers. European Journal of Clinical Pharmacology, v. 72, n. 2, p. 195-201, 2016Tradução . . Disponível em: https://doi.org/10.1007/s00228-015-1970-4. Acesso em: 01 nov. 2024.
APA
Antunes, N. de J., Wichert-Ana, L., Coelho, E. B., Pasqua, O. D., Alexandre Junior, V., Takayanagui, O. M., et al. (2016). Influence of verapamil on the pharmacokinetics of oxcarbazepine and of the enantiomers of its 10-hydroxy metabolite in healthy volunteers. European Journal of Clinical Pharmacology, 72( 2), 195-201. doi:10.1007/s00228-015-1970-4
NLM
Antunes N de J, Wichert-Ana L, Coelho EB, Pasqua OD, Alexandre Junior V, Takayanagui OM, Tozatto E, Marques MP, Lanchote VL. Influence of verapamil on the pharmacokinetics of oxcarbazepine and of the enantiomers of its 10-hydroxy metabolite in healthy volunteers [Internet]. European Journal of Clinical Pharmacology. 2016 ; 72( 2): 195-201.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1007/s00228-015-1970-4
Vancouver
Antunes N de J, Wichert-Ana L, Coelho EB, Pasqua OD, Alexandre Junior V, Takayanagui OM, Tozatto E, Marques MP, Lanchote VL. Influence of verapamil on the pharmacokinetics of oxcarbazepine and of the enantiomers of its 10-hydroxy metabolite in healthy volunteers [Internet]. European Journal of Clinical Pharmacology. 2016 ; 72( 2): 195-201.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1007/s00228-015-1970-4
Artigo de periodico
Impact of fraction unbound, CYP3A, and CYP2D6 in vivo activities, and other potential covariates to the clearance of tramadol enantiomers in patients with neuropathic pain (2016)
Moraes, Natália V. de; Lauretti, Gabriela Rocha; Coelho, Eduardo Barbosa; Godoy, Ana Leonor P. C.; Neves, Daniel V.; Lanchote, Vera Lúcia
Source: Fundamental and Clinical Pharmacology. Unidades: FMRP, FCFRP
Subjects: ANALGÉSICOS, CITOCROMO P-450, ESTEROIDES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MORAES, Natália V. de et al. Impact of fraction unbound, CYP3A, and CYP2D6 in vivo activities, and other potential covariates to the clearance of tramadol enantiomers in patients with neuropathic pain. Fundamental and Clinical Pharmacology, v. 30, n. 2, p. 153-161, 2016Tradução . . Disponível em: https://doi.org/10.1111/fcp.12168. Acesso em: 01 nov. 2024.
APA
Moraes, N. V. de, Lauretti, G. R., Coelho, E. B., Godoy, A. L. P. C., Neves, D. V., & Lanchote, V. L. (2016). Impact of fraction unbound, CYP3A, and CYP2D6 in vivo activities, and other potential covariates to the clearance of tramadol enantiomers in patients with neuropathic pain. Fundamental and Clinical Pharmacology, 30( 2), 153-161. doi:10.1111/fcp.12168
NLM
Moraes NV de, Lauretti GR, Coelho EB, Godoy ALPC, Neves DV, Lanchote VL. Impact of fraction unbound, CYP3A, and CYP2D6 in vivo activities, and other potential covariates to the clearance of tramadol enantiomers in patients with neuropathic pain [Internet]. Fundamental and Clinical Pharmacology. 2016 ; 30( 2): 153-161.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1111/fcp.12168
Vancouver
Moraes NV de, Lauretti GR, Coelho EB, Godoy ALPC, Neves DV, Lanchote VL. Impact of fraction unbound, CYP3A, and CYP2D6 in vivo activities, and other potential covariates to the clearance of tramadol enantiomers in patients with neuropathic pain [Internet]. Fundamental and Clinical Pharmacology. 2016 ; 30( 2): 153-161.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1111/fcp.12168
Artigo de periodico
Influence of chronic kidney disease and haemodialysis treatment on pharmacokinetics of nebivolol enantiomers (2016)
Neves, Daniel V.; Lanchote, Vera Lúcia; Moysés Neto, Miguel; Costa, José Abrão Cardeal da; Vieira, Carolina P.; Coelho, Eduardo Barbosa
Source: British Journal of Clinical Pharmacology. Unidades: FCFRP, FMRP
Subjects: NEFROPATIAS, FARMACOCINÉTICA, FENÓTIPOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NEVES, Daniel V. et al. Influence of chronic kidney disease and haemodialysis treatment on pharmacokinetics of nebivolol enantiomers. British Journal of Clinical Pharmacology, v. 82, n. 1, p. 83-91, 2016Tradução . . Disponível em: https://doi.org/10.1111/bcp.12917. Acesso em: 01 nov. 2024.
APA
Neves, D. V., Lanchote, V. L., Moysés Neto, M., Costa, J. A. C. da, Vieira, C. P., & Coelho, E. B. (2016). Influence of chronic kidney disease and haemodialysis treatment on pharmacokinetics of nebivolol enantiomers. British Journal of Clinical Pharmacology, 82( 1), 83-91. doi:10.1111/bcp.12917
NLM
Neves DV, Lanchote VL, Moysés Neto M, Costa JAC da, Vieira CP, Coelho EB. Influence of chronic kidney disease and haemodialysis treatment on pharmacokinetics of nebivolol enantiomers [Internet]. British Journal of Clinical Pharmacology. 2016 ; 82( 1): 83-91.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1111/bcp.12917
Vancouver
Neves DV, Lanchote VL, Moysés Neto M, Costa JAC da, Vieira CP, Coelho EB. Influence of chronic kidney disease and haemodialysis treatment on pharmacokinetics of nebivolol enantiomers [Internet]. British Journal of Clinical Pharmacology. 2016 ; 82( 1): 83-91.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1111/bcp.12917
Artigo de periodico
Chiral analysis of carvedilol and its metabolites hydroxyphenyl carvedilol and O-desmethyl carvedilol in human plasma by liquid chromatography-tandem mass spectrometry: application to a clinical pharmacokinetic study (2016)
Nardotto, Glauco Henrique Balthazar; Coelho, Eduardo Barbosa; Marques, Maria Paula; Lanchote, Vera Lúcia
Source: Journal of Chromatography B. Unidades: FMRP, FCFRP
Subjects: ESPECTROMETRIA DE MASSAS, REPRODUTIBILIDADE DE RESULTADOS, CROMATOGRAFIA LÍQUIDA, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NARDOTTO, Glauco Henrique Balthazar et al. Chiral analysis of carvedilol and its metabolites hydroxyphenyl carvedilol and O-desmethyl carvedilol in human plasma by liquid chromatography-tandem mass spectrometry: application to a clinical pharmacokinetic study. Journal of Chromatography B, v. 1015, p. 173-180, 2016Tradução . . Disponível em: https://doi.org/10.1016/j.jchromb.2016.02.028. Acesso em: 01 nov. 2024.
APA
Nardotto, G. H. B., Coelho, E. B., Marques, M. P., & Lanchote, V. L. (2016). Chiral analysis of carvedilol and its metabolites hydroxyphenyl carvedilol and O-desmethyl carvedilol in human plasma by liquid chromatography-tandem mass spectrometry: application to a clinical pharmacokinetic study. Journal of Chromatography B, 1015, 173-180. doi:10.1016/j.jchromb.2016.02.028
NLM
Nardotto GHB, Coelho EB, Marques MP, Lanchote VL. Chiral analysis of carvedilol and its metabolites hydroxyphenyl carvedilol and O-desmethyl carvedilol in human plasma by liquid chromatography-tandem mass spectrometry: application to a clinical pharmacokinetic study [Internet]. Journal of Chromatography B. 2016 ; 1015 173-180.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1016/j.jchromb.2016.02.028
Vancouver
Nardotto GHB, Coelho EB, Marques MP, Lanchote VL. Chiral analysis of carvedilol and its metabolites hydroxyphenyl carvedilol and O-desmethyl carvedilol in human plasma by liquid chromatography-tandem mass spectrometry: application to a clinical pharmacokinetic study [Internet]. Journal of Chromatography B. 2016 ; 1015 173-180.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1016/j.jchromb.2016.02.028

USP Schools

ReP

Filtros

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Publisher

Conference titles

Countries/Territories

Funding Agencies

Indexado em

Non normalized affiliation